Inovio Pharmaceuticals Inc. Stock Falls 4.8%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. shed 4.8% to $0.99 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.1% to 26,140.03 and Dow Jones Industrial Average falling 0.3% to 52,002.41.

Inovio Pharmaceuticals Inc. closed 63.6% below its 52-week high of $2.72, which the company reached on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $255.56, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.48% to $29.58.

Trading volume totaled 2.0 million, compared to the 50-day average of 3.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 16, 2026 16:35 ET (20:35 GMT)